跳轉至內容
Merck
  • Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis.

Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis.

Experimental hematology (2008-07-29)
Loyal A Goff, Shayne Boucher, Christopher L Ricupero, Sara Fenstermacher, Mavis Swerdel, Lucas G Chase, Christopher C Adams, Jonathan Chesnut, Uma Lakshmipathy, Ronald P Hart
摘要

Human multipotent mesenchymal stromal cells (MSC) have the potential to differentiate into multiple cell types, although little is known about factors that control their fate. Differentiation-specific microRNAs may play a key role in stem cell self-renewal and differentiation. We propose that specific intracellular signaling pathways modulate gene expression during differentiation by regulating microRNA expression. Illumina mRNA and NCode microRNA expression analyses were performed on MSC and their differentiated progeny. A combination of bioinformatic prediction and pathway inhibition was used to identify microRNAs associated with platelet-derived growth factor (PDGF) signaling. The pattern of microRNA expression in MSC is distinct from that in pluripotent stem cells, such as human embryonic stem cells. Specific populations of microRNAs are regulated in MSC during differentiation targeted toward specific cell types. Complementary mRNA expression analysis increases the pool of markers characteristic of MSC or differentiated progeny. To identify microRNA expression patterns affected by signaling pathways, we examined the PDGF pathway found to be regulated during osteogenesis by microarray studies. A set of microRNAs bioinformatically predicted to respond to PDGF signaling was experimentally confirmed by direct PDGF inhibition. Our results demonstrate that a subset of microRNAs regulated during osteogenic differentiation of MSCs is responsive to perturbation of the PDGF pathway. This approach not only identifies characteristic classes of differentiation-specific mRNAs and microRNAs, but begins to link regulated molecules with specific cellular pathways.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
地塞米松, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
L -抗坏血酸, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L -抗坏血酸, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
胰岛素 来源于牛胰腺, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
胰岛素 来源于牛胰腺, γ-irradiated, BioXtra, suitable for cell culture, potency: ≥20 units/mg (USP units), lyophilized powder
Sigma-Aldrich
L -抗坏血酸, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
地塞米松, ≥98% (HPLC), powder
Sigma-Aldrich
L -抗坏血酸, reagent grade, crystalline
Sigma-Aldrich
吲哚美辛, 98.5-100.5% (in accordance with EP)
Supelco
L -抗坏血酸, analytical standard
Sigma-Aldrich
L -抗坏血酸, reagent grade
Sigma-Aldrich
L -抗坏血酸, meets USP testing specifications
Sigma-Aldrich
地塞米松, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
L -抗坏血酸, FCC, FG
Sigma-Aldrich
L -抗坏血酸, 99%
Sigma-Aldrich
L -抗坏血酸, BioUltra, ≥99.5% (RT)
Supelco
油红O, BioReagent, suitable for electrophoresis
Sigma-Aldrich
吲哚美辛, meets USP testing specifications
Sigma-Aldrich
胰岛素 来源于牛胰腺, Hybri-Max, powder, suitable for hybridoma
Sigma-Aldrich
油红O, certified by the Biological Stain Commission
Supelco
维生素C, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L -抗坏血酸, ACS reagent, ≥99%
Sigma-Aldrich
地塞米松, meets USP testing specifications
Sigma-Aldrich
L -抗坏血酸, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Sigma-Aldrich
胰岛素 来源于牛胰腺, ≥25 USP units/mg (HPLC), powder
Sigma-Aldrich
L -抗坏血酸, puriss. p.a., ≥99.0% (RT)
Sigma-Aldrich
L -抗坏血酸, tested according to Ph. Eur.
Sigma-Aldrich
地塞米松, tested according to Ph. Eur.
Supelco
地塞米松, VETRANAL®, analytical standard